Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
α-Synuclein and tau deposition in the central nervous system is responsible for various parkinsonian syndromes, including Parkinson’s disease, multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. Emerging evidence has suggested that pathol...
Main Authors: | Junghwan Shin, Han-Joon Kim, Beomseok Jeon |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Movement Disorders Society
2020-01-01
|
Series: | Journal of Movement Disorders |
Subjects: | |
Online Access: | http://www.e-jmd.org/upload/jmd-19057.pdf |
Similar Items
-
Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
by: Martin Kallab, et al.
Published: (2018-07-01) -
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01) -
Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
by: Fiona Limanaqi, et al.
Published: (2020-04-01) -
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
by: Maria Fouka, et al.
Published: (2020-09-01) -
Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
by: Jacqui Nimmo, et al.
Published: (2020-01-01)